Department of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA 98111, USA.
Dis Esophagus. 2013 Apr;26(3):250-62. doi: 10.1111/j.1442-2050.2012.01353.x. Epub 2012 May 16.
The incidence of esophageal malignancy continues to increase worldwide. At the same time, average life expectancy levels continue to climb, ensuring that more patients will present in their 70s, 80s, and 90s. The aim of this pooled analysis is to compare short- and long-term outcomes for elderly and younger patients undergoing esophagectomy for malignancy. Studies comparing the outcomes of esophagectomy for malignancy in elderly and young cohorts of patients were included. The minimum threshold age used to define the elderly cohort was 70 years. Primary outcomes were in-hospital mortality, overall and cancer-related 5-year survival. Secondary outcomes were the length of hospital stay, the incidence of anastomotic leak, conduit ischemia, cardiac and pulmonary complications, and the use of neoadjuvant therapy. Twenty-five publications comprising 9531 and 2573 operations on younger and elderly cohorts of patients respectively were analyzed. Elderly patients were less likely to receive neoadjuvant therapy (14.6% vs. 29.47%; pooled odds ratio [POR]= 0.48; 95% confidence interval [C.I.]= 0.35-0.65; P < 0.05). Esophagectomy in elderly patients was associated with increased in-hospital mortality (7.83% vs. 4.21%; POR = 1.87; 95% C.I. = 1.54-2.26; P < 0.05), as well as increased pulmonary (21.77% vs. 19.49%) and cardiac (18.7% vs. 13.17%) complications. Subset analysis of studies using an age threshold of 80 years showed an even more significant association between in-hospital mortality and elderly age (pooled odds ratio = 3.19; 95% C.I. = 1.6-6.35; P < 0.05). There were no significant differences between the groups in length of hospital stay, incidence of anastomotic leak, or conduit ischemia. The elderly group showed reduced overall 5-year survival (21.23% vs. 29.01%; pooled odds ratio = 0.73; 95% C.I. = 0.62-0.87; P < 0.05) and reduced cancer-free 5-year survival (34.4% vs. 41.8%; POR = 0.75; 95% C.I. = 0.64-0.89; P < 0.05). Elderly patients are at increased risk of pulmonary and cardiac complications, and perioperative mortality following esophagectomy, and show reduced cancer-related 5-year survival compared with younger patients. These patients represent a high-risk cohort, who requires thorough assessment of medical comorbidity, targeted counseling, and optimized treatment pathways.
食管恶性肿瘤的发病率在全球范围内持续上升。与此同时,平均预期寿命水平持续攀升,这意味着更多的患者将在 70 多岁、80 多岁和 90 多岁时出现。本荟萃分析旨在比较接受恶性肿瘤食管切除术的老年患者和年轻患者的短期和长期结局。纳入了比较老年和年轻患者队列接受恶性肿瘤食管切除术结局的研究。定义老年队列的最小年龄阈值为 70 岁。主要结局为院内死亡率、总生存率和癌症相关 5 年生存率。次要结局为住院时间、吻合口漏、移植物缺血、心脏和肺部并发症的发生率以及新辅助治疗的使用。分析了 25 篇文献,其中包括分别针对年轻和老年患者队列的 9531 例和 2573 例手术。老年患者接受新辅助治疗的可能性较小(14.6% vs. 29.47%;合并优势比 [POR] = 0.48;95%置信区间 [C.I.] = 0.35-0.65;P < 0.05)。老年患者行食管切除术与院内死亡率增加相关(7.83% vs. 4.21%;POR = 1.87;95% C.I. = 1.54-2.26;P < 0.05),肺部(21.77% vs. 19.49%)和心脏(18.7% vs. 13.17%)并发症发生率也更高。使用 80 岁年龄阈值的研究的亚组分析显示,院内死亡率与老年年龄之间的相关性更为显著(合并优势比 = 3.19;95% C.I. = 1.6-6.35;P < 0.05)。两组间住院时间、吻合口漏或移植物缺血的发生率无显著差异。老年组总 5 年生存率降低(21.23% vs. 29.01%;合并优势比 = 0.73;95% C.I. = 0.62-0.87;P < 0.05),癌症无进展 5 年生存率降低(34.4% vs. 41.8%;POR = 0.75;95% C.I. = 0.64-0.89;P < 0.05)。与年轻患者相比,老年患者行食管切除术围手术期死亡率更高,且更易发生肺部和心脏并发症,癌症相关 5 年生存率降低。这些患者属于高危人群,需要对合并症进行全面评估、有针对性的咨询和优化的治疗途径。